Researchers from Tokyo Medical and Dental University (TMDU) have uncovered a link between cardiovascular disease and chronic kidney disease, revealing novel disease biomarkers and therapeutic targets. Chronic kidney disease is linked to the...
Read More »EXOSOME NEWS
Extracellular vesicles can be isolated from CF patients’ blood
A recent study led by researchers at Children’s Health Ireland investigated the presence of extracellular vesicles (EVs) in the blood of patients with cystic fibrosis (CF). EVs are small membrane...
Read More »Is saliva the next frontier in cancer detection?
In recent years, there has been growing interest in the potential of exosomes for cancer detection and diagnosis. Exosomes are tiny vesicles that are released by cells into bodily fluids, such as blood...
Read More »Senescence-associated exosomes transfer miRNA-induced fibrosis to neighboring cells
Radiation-induced fibrosis is a common side effect of radiotherapy, which is the most common treatment for cancer. However, radiation also causes p53...
Read More »Small extracellular vesicles or exosomes: structural analysis in atherosclerotic cardiovascular disease using electron microscopy techniques
Small extracellular vesicles (sEVs) or exosomes are secretory vesicles largely involved in cell–cell communications and found to play a role in development as...
Read More »Oxford Nanopore Technologies and Cyclomics collaborate on non-invasive liquid biopsy method for cancer biomarker detection
Research collaboration has resulted in new ‘liquid biopsy’ research workflow using nanopore sequencing to detect molecules that are associated with cancer, circulating in blood Oxford Nanopore...
Read More »K-State research that successfully generates neurons using exosomes could help develop therapeutic interventions
Kansas State University researchers have led a newly published study that is helping unlock some of the secrets of specific cellular messengers called exosomes. The work could one day lead to therapeutic...
Read More »Direct Biologics reports compelling results from phase 2 trial of ExoFlo™ treatment in COVID-19 patients
Direct Biologics, a late-stage biotechnology company leveraging its regenerative medicine platform using extracellular vesicles (EVs) derived from bone marrow mesenchymal stem cells (MSCs) to address...
Read More »iNEBULA – interaction network of extracellular vesicles building universal analysis via eye tears
Discovering the secrets of diseases from tear extracellular vesicles (EVs) is well-recognized and appreciated. However, a precise understanding of the interaction network between EV populations and their biogenesis from our body requires more in...
Read More »Systemic delivery of extracellular vesicles attenuates atrial fibrillation in heart failure with preserved ejection fraction
Atrial fibrillation (AF) is a common comorbidity in heart failure with preserved ejection fraction (HFpEF) patients. To date, treatments for HFpEF-related AF have been limited to anti-arrhythmic drugs...
Read More »Jobs
-
Postdoc position available – cardiac extracellular vesicles
We are looking for a positive and energetic individual with experience in extracellular vesicles, cell culture, proteomics, RNA seq, bioinformatics, confocal microscopy and FACS...
Read More » -
PhD Opportunity – visualizing extracellular vesicle secretion from brain cancer cells
-
PhD Opportunity – upstream platform development for the production of therapeutic exosomes
-
Post-doc Position Available – Cancer and Infectious Disease Biomarkers
-
Featured Exosomes Job – Production Specialist In Extracellular Vesicles
Industry News
-
Oxford Nanopore Technologies and Cyclomics collaborate on non-invasive liquid biopsy method for cancer biomarker detection
Research collaboration has resulted in new ‘liquid biopsy’ research workflow using nanopore sequencing to detect molecules that are associated with cancer, circulating in blood Oxford Nanopore...
Read More » -
Direct Biologics reports compelling results from phase 2 trial of ExoFlo™ treatment in COVID-19 patients
-
RoosterBio and Repligen collaborate to advance scalable exosome bioprocessing
-
Ovarian Cancer 97 study confirms EXO-NET utility for EV biomarker discovery
-
ExoCoBio Obtains 2 GMP Licenses for Exosome Biopharmaceuticals